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New palladacyclopentadiene compounds containing different chelate NHC-thioether and NHC-pyridine
ligands have been prepared by transfer of the functionalized carbenes from the respective silver com-
plexes to the polymeric precursors [PdCeCOOR)4]n (R ¼ Me, t-Bu). Their dynamic behaviour in solution
was discussed and the solid-structure of 2c was determined by X-ray crystallography.
The treatment of [Pd(CeCOOCH3)4]n with two equivalents of the carbene silver complexes led to the
(NHC)2Pd(C4eCOOCH3)4 derivatives (3cei), a new class of compounds with only PdeC bonds. A serious
limitation to this synthetic procedure is an excessive steric crowding around the metal centre.
The complexes 3 are present in solution as a mixture of two atropoisomers, due to restricted rotation
around the CarbeneePd bond. The kinetics of equilibration between the two conﬁgurational isomers was
studied for complex 3c, which was also structurally deﬁned by X-ray crystallography (anti isomer).
Finally a synthetic protocol was set up for the synthesis of mixed NHC-Phosphine and NHC-Isocyanide
palladacyclopentadiene complexes. In this procedure the order of addition of the reactants is of great
importance.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The palladacyclopentadiene fragment Pd(CeCOOR)4 is an
interesting organometallic building unit that is obtained by
oxidative homocoupling of acetylenic esters to Pd(0) substrates [1]
and the mechanistic study of this process was the subject of some
previous publications by our group [2]. Its synthetic importance
arises from the fact that this organometallic functional group was
involved in the Pd(0)-catalysed [2þ2þ2] alkyne cyclotrimerization
and cocyclotrimerization of acetylenes with alkenes, dienes or
allenes [1e3]. Furthermore its reactivity toward organic halides or
molecular halogens resulted in the production of (s-dienyl)palla-
dium compounds formed by a sequence of oxidative addition/
reductive elimination through a transient Pd(IV) intermediate
(Scheme 1) [4]. Remarkably such process was stereospeciﬁc and
usually only the cis-arrangement of the esteric functions at the
double bonds was obtained. Since the addition of molecularhalogens [4] or organotin [5] reagents allowed the displacement of
the dienyl fragment from the metal, it was possible to take
advantage of this synthetic strategy to produce dienes with a ZeZ
conﬁguration. In this respect only a limited number of methods are
available for the stereospeciﬁc preparation of dienes from acety-
lenes [6].
In this context the features of spectator ligands are of great
importance; it was proved that the ability to couple two alkynes
decreases with the p-acceptor capability and steric bulkiness of the
ancillary ligands of the starting Pd(0) compounds. In some cases the
monoalkyne-Pd(0) complexes were isolated instead of the palla-
dacyclopentadiene derivatives even with excess of alkynes (i.e.
with L¼ P(OPh)3 [1b], or LeL¼ 2,9-dimethylphenanthroline [7]). In
any case several mononuclear complexes [L2Pd(C-COOR)4] are re-
ported in the literature with monodentate or bidentate supporting
ligands [1,2a,3d,8]. Among themN-heterocyclic carbenes have been
scantily utilized in spite of their ubiquitous utilization as spectator
ligands in palladium organometallic chemistry [9] and to the best of
our knowledge the two examples shown in Scheme 2 only have
been described so far.
Complex a was observed by Elsevier and co-workers as a by-
Scheme 1. Reactivity of the palladacyclopentadiene fragment.
Scheme 2. The two palladacyclopentadiene complexes bearing N-heterocyclic car-
benes ligands described in the literature.
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[10] whereas complex bwas detected by our group when studying
the reaction of [(MeeNHCeCH2Py)Pd(h2-MA)] (MA ¼ maleic an-
hydride) with an excess of dimethylbutynedioate [11].
In the present paper we intend to partially ﬁll this gap by
describing the general procedures for the synthesis of some
different classes of palladacyclopentadienes stabilized by NHC li-
gands. Furthermore the structural features and solution behaviour
of these new complexes will be discussed in detail.Scheme 3. N-heterocyclic carbene ligands used in this work.The monodentate or heteroditopic N-heterocyclic carbene li-
gands employed are summarized in Scheme 3.2. Results and discussion
2.1. NHC-pyridine and NHC-thioether chelate
palladacyclopentadiene complexes
The silver-mediated transfer of functionalized carbene ligands
onto appropriate palladium precursors was the synthetic strategy
employed to achieve the title complexes [12]. In more detail these
compounds were prepared by stoichiometric treatment of the
respective silver complexes 1 [13] with the polymeric precursors
[Pd(C-COOR)4]n [2a] (R ¼ Me, t-Bu), in dichloromethane at room
temperature. The precipitation of silver bromide was observed
almost immediately and the ﬁnal products could be easily isolated
from the reaction mixtures after ﬁltration.
All the complexes reported in Scheme 4 were obtained in high
yield and purity, independently of the nature of the second coor-
dinating function (pyridyl or methylthioether group), the number
of chelate ring members (ﬁve or six) and substituents (COOMe or
COOt-Bu) on the cyclometallated system. The only exception is
represented by the reaction of the scarcely bulky complex 1f, which
preferentially produces the bis-carbene complex (see Scheme 5),
leaving half [Pd(C-COOR)4] polymer unreacted.
The resulting complexes 2 were mainly characterized by NMR
spectroscopy. The deﬁnitive proof of the chelating coordination
mode of the heteroditopic ligands is the splitting of the methylene
linker signals into an AB system (or two doublets) in the 1H NMR
spectra recorded at 253 K. However, due to ﬂipping [14] of chelate
ring (or rapid in-place inversion of stereogenic sulphur [15] atom
for the complexes 2d and 2e), which renders the coordination plane
as the symmetry plane of themolecule, these signals are broadened
at room temperature. Notably for the most sterically hindered
complexes 2a′, 2b′ and 2c′, this movement becomes operative only
at higher temperatures. Furthermore the 1H NMR spectra at 253 K
of the complexes bearing the bulky substituents on the heterocyclic
nitrogen atoms (Mes or DiPP), exhibit two different signals for the
ortho methyl or ortho i-propyl groups and for the meta-hydrogens
stemming from the hindered rotation around the CeN bond. For
the less sterically crowded cyclopalladate systems 2ae2d, this
rotation restriction is overcome at 298 K and complete coalescence
of the signals can be observed.
In the 13C NMR spectra the signals of the coordinated carbenic
Scheme 4. Synthesis of the chelate complexes 2.
Scheme 5. Synthesis of the bis(NHC) palladacyclopentadiene complexes 3.
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compare well with the reported literature data for divalent palla-
dium species bearing similar ligands [16]. Finally the presence of
the palladacyclopentadiene fragment is clearly testiﬁed by the four
distinguishable systems of signals relative to the four different
COOR groups observed in both 1H and 13C NMR spectra of all
complexes 2.
Our expectations were conﬁrmed by X-ray analysis of complex
2c, crystals of which were grown by slow diffusion of diethyl etherin a dichloromethane solution (an ORTEP [17] view is shown in
Fig. 1 and a selection of bond distances and angles is summarized in
Table 1).
The geometry around the palladium centre is distorted square
planar tending toward a tetrahedral arrangement. The four posi-
tions around the central Pd are occupied by the 1,4 carbons of the
1,2,3,4-tetrakis(methoxycarbonyl)buta-1,3-diene-1,4-diyl anionic
ligand, the pyridine nitrogen and the carbene carbon of the ligand.
The deviations from the basal plane are: 0.053(2) for N3,
Fig. 1. ORTEP view of complex 2c showing the thermal ellipsoids at 30% probability
level.
Table 1
Selected bond distances and angles (Å and degrees) for 2c and 3i.
Distances 2c 3i
Pd1eC1 2.027(2) 2.084(3)
Pd1eN3 2.140(2)
Pd1eC11 2.013(2) 2.040(3)
Pd1eC14 2.072(2)
C11eC12 1.338(3) 1.347(4)
C12eC13 1.475(3)
C12eC120 1.490(6)
C13eC14 1.349(3)
Angles
C1ePd1eN3 83.94(8)
C1ePd1eC10 94.25(17)
C1ePd1eC11 95.01(9) 171.96(13)
C1ePd1eC110 93.36(11)
C1ePd1eC14 173.91(9)
N3ePd1eC11 175.40(8)
N3ePd1eC14 101.88(8)
C11ePd1eC14 79.32(9)
C11ePd1eC110 79.16(17)
Scheme 6. Antropoisomers of the complexes 3: NOE interaction in the anti isomer.
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palladacyclopentadiene ring is approximately planar with a
maximum deviation from themean plane for C14 of 0.052(1) Å. The
Pd1eC14 and Pd1eC1(NHC) bonds (2.072(2) and 2.027(2) Å) are
somewhat lengthened due to the mutual trans-inﬂuence, as
compared to the PdeC11 distance of 2.013(2) Å and to the PdeC
average bond length of 2.00 Å observed in Pd complexes with the
same anionic ligand where the carbon atoms are in trans position to
nitrogens [2a,4,18].
2.2. Bis(NHC) palladacyclopentadiene complexes
When the [Pd(CeCOOR)4] precursor was treated with two
equivalents of the silver complexes 1c, 1fei, it gave smoothly andexclusively the bis-carbene derivatives 3 (Scheme 5):
It is worth noting that these complexes were obtained only by
reducing the steric crowding of the reactants. In particular one of
the N-substituents of the imidazolium scaffold was in any case the
small methyl fragment and the electron-withdrawing substituents
of the cyclometalladed system were the less encumbered COOMe
groups. On the contrary the reaction between [Pd(CeCOOR)4]n and
the bulky silver complexes 1a and 1b or 1d and 1e produced un-
failingly the corresponding chelate derivatives even in the presence
of a large excess of silver substrate. An analogous result was
observed using the sterically demanding [Pd(CeCOOt-Bu)4]n with
any of the silver complexes 1.
At variance, as we have already reported, in the case of the less
hindered silver complex 1f the bis-chelate derivative 3f was pro-
duced exclusively, even when employing a defect of silver reactant.
The criticality of steric features in these systems is apparent
when observing the X-ray crystal structure of complex 3c (see
later).
The 1H and 13C NMR spectra of complexes 3 show two sets of
signals suggesting the presence in solution of a mixture of two
conﬁgurational isomers. We surmise that this differentiation arises
from the two possible orientations of the wingtip imidazole sub-
stituents with respect to the coordination plane (Scheme 6).
The assignment of the signals of each isomer is based on an
NOESY experiment, which shows for the anti isomer an intense
cross peak between one of the bridged CH2 protons of the ﬁrst
ligand and the NeCH3 group of the other.
The NMR spectra of each isomer of species 3 are simpliﬁed in
comparison with those of the corresponding chelate derivatives 2.
The higher symmetry of the compounds reduces to half the number
of different OCH3 signals in 1H NMR spectra of OCH3, CO and
cyclometallated C]C in the 13C NMR spectra.
Moreover, provided that the imidazole rings are substantially
perpendicular to the Pd-coordination plane (see later the X-Ray
structure of complex 3c), the two methylene links in each isomer
will be diasterotopic. This will generate a splitting of the 1H NMR
signals into mutually coupled doublets (or into an AB system).
All the 13CNHCePd resonances fall in the narrow range of
180e182 ppm, differing signiﬁcantly from the shifts of other
neutral cis-(NHC)2Pd(II) species reported in the literature (e.g. for
cis-(NHC)2PdMe2 d z 200 ppm [19] and for cis-(NHC)2PdX2
d z 170e175 ppm [20]).
The rate of interconversion between the syn and anti derivatives
depends on the rotation barrier around the PdeC(carbene) bond
whereas the relative ﬁnal abundance is determined by the relative
stabilities of the two atropoisomers. In our systems these param-
eters are such that, starting from the initial composition obtained
immediately after the transmetalation process [21], the ﬁnal
Fig. 3. ORTEP view of complex 3i (anti isomer) showing the thermal ellipsoids at 30%
probability level.
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solution at room temperature) with a predominance of the syn
isomers ([syn]/[anti] z 2 for the NHC-thioether complexes 3f and
3g and z3 for the NHC-aryl complexes 3h and 3i). A partial
exception is represented by the NHC-pyridine complex 3c, for
which the equilibration is faster, requiring about three days. This
circumstance allows a detailed kinetic study. In particular a set of
concentration vs time data for the isomers anti and syn could be
obtained with high precision from the relevant 1H NMR signals of a
solution of the isolated complex 3c [21] (Fig. 2).
In this case we observed that the changes in the concentrations
of the anti and syn isomers followed a reversible ﬁrst-order rate law
according to the differential equation:
rate ¼ k1½anti  k1½syn (1)
Data analysis yielded the rate constants
k1¼ (6.41 ± 0.02) 106 s1 and k1¼ (1.85 ± 0.01) 106 s1. The
equilibrium constant calculated as the ratio of rate constants
(KE ¼ 3.47 ± 0.03) agrees well with the estimated value obtained
from integration of the 1H NMR spectra of the ﬁnal equilibrium
mixture (KE ¼ 3.6). Moreover a DFT calculation indicated that the
anti isomer is more stable than the syn isomer, with a
DG ¼ 0.6 kcal/mol, corresponding to a value of KE ¼ 2.75, in
reasonable accord with the experimental data. Apparently the anti
conﬁguration guarantees a lower steric strain in the structure of the
complex.
In other respects the ﬁrst order dependence of the rate strongly
supports the hypothesis of an intramolecular rearrangement
(rotation around the PdeC(carbene) bond) and rules out the pos-
sibility of a bimolecular process such as the exchange between two
carbene ligands bonded to different metal centres. The latter
mechanistic option was previously proposed in the case of unsat-
urated Pd(0) complexes [22] or of less encumbered Pd(h3-allyl)
compounds [13], but it does not seem feasible in these sterically
congested systems.
Finally the higher rate of isomerization recorded for complex 3c
with respect to the iso-structural species 3h suggests some sort of
assistance by the pyridine nitrogen in the rotational process.
Crystals of the anti isomer of complex 3c suitable for X-ray
diffraction structure determination were obtained by crystalliza-
tion from diethyl ether-dichloromethane. An ORTEP [17] view of
this complex is shown in Fig. 3 and a selection of bond distances
and angles is given in Table 1.Fig. 2. Fit of concentrations of isomers anti and syn of the species 3c to time according
to eq. (1) in CD2Cl2 at 25 C ([3c]tot ¼ 1.3  102 mol dm3).The structure displays a C2 symmetry with the crystallographic
twofold axis passing through the palladium atom and the mid-
point of the C12eC120 bond.
The geometry around the palladium centre is distorted square
planar toward a tetrahedral arrangement. The four positions
around the central Pd are occupied by the 1,4 carbons of the
cyclometallated system and two C(carbene) atoms of two NHC li-
gands. The deviations of the four carbons from the basal plane are:
0.046(3) for C1, 0.046(3) for C10, 0.054(3) for C11 and 0.054(3) Å
for C110. The palladacyclopentadiene ring is approximately planar
with maximum deviations from the mean plane for C12 and C120 of
0.027(3) and 0.27(3) Å, respectively. The Pd1eC1 and Pd1eC11
bond distances of 2.079(3) and 2.046(2) Å indicate mutual trans
inﬂuence if compared with PdeC(carbene) bonds (having distances
in the range of 1.96e2.00 Å), as observed in Pd complexes where
the PdeC(carbene) bonds are in trans positions to nitrogen atoms
[23]. The carbene(NHC) trans-inﬂuence can be highlighted also in
Pd trans biscarbene complexes where the PdeC(carbene) bonds in
mutual trans position display a signiﬁcant PdeC lengthening with
distances in the range 2.017e2.137 Å [24].2.3. Mixed NHC-Phoshine and NHC-Isocyanide
palladacyclopentadiene complexes
The most direct synthetic way to achieve the title compounds
was to open the chelate ring of complexes 2, thereby setting a
coordinative site free for an entering ligand.
In the case of NHC-pyridine complex 2c, this procedure was
smooth and the simple addition of an equivalent of PPh3, P(OEt)3 or
2,6-dimethylisocyanide (DIC) allowed the formation of mixed
complexes 5ce7c by selective release of the most labile pyridyl
wing (Scheme 7).
All the three complexes could be isolated and fully
characterized.
The coordination of the P-donor ligands is clearly demonstrated
by the signiﬁcant down-ﬁeld shift of its signal recorded in the 31P
Scheme 7. Synthesis of the mixed NHC-Phoshine and NHC-Isocyanide Palladacyclo-
pentadiene complexes 5c, 6c and 7c.
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(Dd ¼ 13 ppm). Moreover, the presence of DIC in the coordinative
sphere of complex 7c is testiﬁed (in addition to the appearance of
all expected signals of this ligand in the 1H and 13C{1H} NMR
spectra) by the strong peak at 2174 cm1 observed in its IR spec-
trum and ascribable to the CN stretching of the coordinated iso-
cyanide. Finally in all three complexes the removal of the pyridyl
group from themetal center is conﬁrmed by the shift to higher ﬁeld
of the diagnostic H6 and C6 (Dd z 0.5 ppm and Dd z 3 ppm
respectively) with respect to their resonance position in the start-
ing chelate complex 3c.
Encouraged by these results we considered the more general
possibility of using monodentate NHC ligands. From the thermo-
dynamic point of view the simultaneous introduction of one
equivalent of monodentate carbene and of a monodentate phos-
phine or isocyanide ligand into the polymeric precursors
[Pd(CeCOOMe)4]n may produce selectively the mixed complexes
only if these compounds are signiﬁcantly more stable than the two
corresponding homoleptic derivatives. Thus we preliminarily per-
formed a DFT theoretical study to verify such occurrence. The re-
sults are summarised in Scheme 8 [25].
It is apparent that in both cases examined themixed compounds
are thermodynamically favoured. This is probably the consequence
of a synergic “pushepull” stabilization of the two couples of ligands
NHC-triarylphoshine and NHC-isocyanide as some other previous
papers seem to indicate [26]. In any way this necessary prerequisite
does not ensure the success of the synthesis and the problem has to
be considered also from the kinetic point of view. As a matter of
fact, for a fast and clean preparation of the mixed complex 5i or
from the [Pd(CeCOOMe)4] precursor, one equivalent of triphenyl-
phosphine must be added before or simultaneously to one equiv-
alent of the silver carbene derivatives 1i whereas the preliminary
introduction of the latter produces a mixture of complexes
[(PPh3)2Pd(CeCOOMe)4] and [(NHC)2Pd(CeCOOMe)4] (3i). The
subsequent conversion of these two derivatives into the mixed
complex 5i was very slow and associated to an extensivedecomposition to metallic palladium. This experimental piece of
evidence seems to indicate that reactions (a) and (b) are signiﬁ-
cantly faster than (c) and (d) (Scheme 9).
On the other hand, when L is 2,6-dimethylisocyanide (DIC), the
rate of reaction (b) becomes comparable to the rate of reaction (c),
so that prior or simultaneous addition of this ligand with respect to
the silver carbene derivative 1i does not guarantee the immediate
and selective formation of the mixed complex 7i. Consequently a
signiﬁcant amounts of complexes [(DIC)2Pd(CeCOOMe)4] and
[(NHC)2Pd(CeCOOMe)4] (3i) are also initially present in the reac-
tion mixture. These compounds gradually convert into the mixed
species (in this case without decomposition) through reaction (d)
which remains very slow. Summing up the selective synthesis of
themixed complex 7i requires a reaction time of about 48 h and not
just the few minutes required for complex 5i containing
triphenylphosphine.
3. Conclusions
In this contribution we have proposed the synthesis and full
characterization of a scarcely explored class of palladium(II) com-
plexes containing the organometallic building unit Pd(C-COOR)4
and N-heterocyclic carbene ligands with various substituents in the
wingtip position. The presence of a second coordinating function
on the ligands has allowed us to obtain k2-C,N or k2-C,S chelate
structures with one pyridyl-carbene or one thioethereal-carbene
moiety per metal upon coordination at the palladium center. We
have shown that the ﬂuxional behaviour of these new compounds
is strictly correlated with the nature of the second coordinating
function and the steric strain of the whole system.
On the other hand, the introduction of two equivalents of the
less encumbered ligands per unity of Pd(CeCOOMe)4 has led to the
selective synthesis of bis-NHC complexes which represent a rare
class of organopalladium complexes with only PdeC bonds. These
derivatives are present in solution as a mixture of two conﬁgura-
tional isomers differing for the two possible orientations of the
wingtip imidazole substituents with respect to the coordination
plane. In one case we were able to study the kinetics of equilibra-
tion between the two atropoisomers.
Finally we have deﬁned a synthetic strategy for the selective
preparation of mixed NHC-phoshine and NHC-isocyanide pallada-
cyclopentadiene complexes.
4. Experimental section
4.1. Materials
Unless otherwise stated, all operations were carried out under
an argon atmosphere using standard Schlenk techniques. All sol-
vents were puriﬁed by standard procedures and distilled under
argon immediately prior to use. 1D and 2D-NMR spectra were
recorded on a Bruker 300 Avance spectrometer. Chemical shifts
(ppm) are given relative to TMS (1H and 13C NMR) and 85% H3PO4
(31P NMR).
Peaks are labelled as singlet (s), doublet (d), triplet (t), quartet
(q), multiplet (m) and broad (br). The proton and carbon assign-
ment was performed by 1H-2D COSY, 1H-2D NOESY, 1He13C HMQC
and HMBC experiments.
IR spectra were recorded on a Perkin Elmer Spectrum One
spectrophotometer.
UVeVis spectra were taken on a PerkineElmer Lambda 40
spectrophotometer equipped with a PerkineElmer PTP6 (Peltier
Temperature Programmer) apparatus.
The polymeric precursors [Pd(C-COOR)4]n (R ¼ Me; t-Bu) [2a],
{[1-(2-pyridyl)methylene-3-(2,4,6-trimethyl]imidazolyl-2-ene}
Scheme 8. DG (Kcal mol1) related to complexes 3i, 7i and 5i.
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diisopropylphenyl)]imidazolyl-2-ene}silver bromide (1b)
[14a],{[1-(2-pyridyl)methylene-3-methyl]imidazolyl-2-ene}silver
bromide (1c) [11] ,{[1-(metylthio)methylene-3-(2,4,6-trimethyl)]
imidazolyl-2-ene}silver bromide (1d) [13],{[1-(metylthio)methy-
lene-3-(2,6-diisopropylphenyl)]imidazolyl-2-ene}silver bromide
(1e) [13],{[1-(methylthio)methylene-3-methyl]imidazolyl-2-ene}
silver bromide (1f) [13],{[1-(phenylthio)methylene-3-methyl]imi-
dazolyl-2-ene}silver bromide (1g) [11],{[1-benzyl-3-methyl]imi-
dazolyl-2-ene}silver bromide (1h) [13],{[1-(4-methylphenyl)
methylene-3-methyl]imidazolyl-2-ene}silver bromide (1i) [13],
were prepared according to published procedures.
4.1.1. Synthesis of {[1-(2-pyridyl)methylene-3-(2,4,6-trimethyl]
imidazolyl-2-ene}Pd(CeCOOMe)4 (2a)
To a solution of [Pd(CeCOOMe)4]n (0.086 g, 0.219 mmol) in
30 mL of anhydrous dichloromethane was slowly added 0.102 g
(0.219 mmol) of {[1-(2-pyridyl)methylene-3-(2,4,6-trimethyl]imi-
dazolyl-2-ene}silver bromide (1a) dissolved in 20 mL of anhydrous
dichloromethane. The mixture was stirred for 30 min with the
progressive precipitation of silver bromide, and then it was passed
through a Millipore ﬁlter. The clear solution was concentrated un-
der reduced pressure and the addition of diethylether induced the
precipitation of the title product as a light yellow solid. It was
ﬁltered off and washed with diethyl ether and n-pentane.
Yield 0.124 g (85%). 1H NMR (CD2Cl2, T¼ 298 K, ppm) d: 2.21 (bs,
6H, o-mesityl-CH3), 2.37 (s, 3H, p-mesityl-CH3), 3.24 (s, 3H, OCH3),
3.35 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 3.56 (s, 3H, OCH3), 5.17 (bs,
1H, NCH2), 5.99 (bs, 1H, NCH2), 6.86 (d, J ¼ 1.9 Hz, 1H, CH]CH Im),
7.03 (s, 2H, m-mesityl-H), 7.25 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 7.42
(ddd, J ¼ 7.7, 4.6, 1.3 Hz, 1H, 5-Pyr); 7.60 (d, J ¼ 7.7 Hz, 1H, 3-Pyr);
7.89 (td, J¼ 7.6, 1.7 Hz, 1H, 4-Pyr), 8.64 (d, J ¼ 4.6 Hz, 1H, 6- Pyr). 13C
{1H } NMR (CD2Cl2, 75 MHz, ppm) d: 19.3 (CH3, o-mesityl), 20.6
(CH3, p-mesityl), 50.0 (CH3, COOCH3), 50.8 (CH3, COOCH3), 50.9
(CH3, COOCH3), 51.0 (CH3, COOCH3), 56.3 (CH2, CH2-Pyr), 120.5 (CH,
CH]CH Im),123.6 (CH, CH]CH Im),123.9 (CH, 3-Pyr), 124.4 (CH, 5-Pyr), 129.5 (CH,m-mesityl), 134.0 (C, o-mesityl), 134.8 (C, i-mesityl),
138.3 (C, C]C), 138.8 (CH, 4-Pyr), 140.2 (C, p-mesityl), 149.0 (C, C]
C), 152.8 (CH, 6-Pyr), 153.9 (C, C]C), 154.4 (C, 2-Pyr), 163.4 (C, CO),
166.0 (C, CO), 173.4 (C, CO), 174.8 (C, CO), 178.3 (C, C]C), 183.0 (C,
NHC). IR (KBr): 1700 cm1 (nCO). Anal. Calcd for C30H31N3O8Pd: C,
53.94; H, 4.68; N, 6.29. Found C, 53.84; H, 4.64; N, 6.36%.
4.1.2. Synthesis of {[1-(2-pyridyl)methylene-3-(2,6-
diisopropylphenyl]imidazolyl-2-ene}Pd(CeCOOMe)4 (2b)
This complex was prepared in an analogous manner as that
described for 2a, using 0.079 g (0.203 mmol) of [Pd(CeCOOMe)4]n
and 0.103 g (0.203 mmol) of {[1-(2-pyridyl)methylene-3-(2,6-
diisopropylphenyl)]imidazolyl-2-ene}silver bromide (1b) to yield
a white powder.
Yield: 0.114 g (79%). 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 0.59 (bs,
3H, iPr-CH3),1.19 (bs, 3H, iPr-CH3) 1.59 (bs, 6H, iPr-CH3) 2.78 (bs, 2H,
iPr-CH), 3.09 (s, 3H, OCH3), 3.30 (s, 3H, OCH3), 3.53 (s, 3H, OCH3),
3.54 (s, 3H, OCH3), 5.21 (bs,1H, CH2Py), 6.00 (bs,1H, CH2Py), 6.88 (d,
J ¼ 1.8 Hz, 1H CH]CH Im), 7.21 (d, J ¼ 1.8 Hz, 1H CH]CH Im), 7.29
(d, J ¼ 7.7 Hz, 2H, m-Ph), 7.38e7.45 (m, 2H, p-Ph 5-Py), 7.60 (d,
J ¼ 7.7 Hz, 1H, 3-Py), 7.88 (td, J ¼ 7.7, 1.6 Hz, 1H, 4-Py), 8.57 (d,
J ¼ 4.5 Hz, 1H, 6-Py). 13C {1H} NMR (CD2Cl2, ppm) d: 23.7 (CH3, iPr-
CH3), 26.8 (CH3, iPr-CH3), 28.6 (CH, iPr-CH), 50.0 (CH3, OCH3), 50.8
(CH3, two signals overlapped, OCH3), 51.6 (CH3, OCH3), 56.4 (CH2,
CH2-Pyr), 120.3 (CH, CH]CH Im),123.9 (CH, CH]CH Im),124.2 (CH,
3-Pyr), 124.2 (CH, m-Ph), 125.2 (CH, 5-Pyr), 129.3 (CH, p-Ph), 134.6
(CH, i-Ph),138.9 (CH, 4-Pyr),140.4 (C, C]C),145.0 (C, o-Ph),148.1 (C,
C]C), 152.2 (CH, 6-Pyr), 154.6 (CH, 2-Pyr), 155.3 (C, C]C), 163.6 (C,
CO), 165.8 (C, CO), 173.5 (C, CO), 174.6 (C, CO), 177.0 (C, C]C), 183.8
(C, NHC). IR (KBr): 1697 cm1 (nCO). Anal. Calcd for C33H37N3O8Pd:
C, 55.82; H, 5.25; N, 5.92. Found C, 55.94; H, 5.20; N, 5.87%.
4.1.3. Synthesis of {[1-(2-pyridyl)methylene-3-methyl]imidazolyl-
2-ene}Pd(CeCOOMe)4 (2c)
This complex was prepared in an analogous manner as that
described for 2a, using 0.114 g (0.291 mmol) of [Pd(CeCOOMe)4]n
Scheme 9. Reactions involved in the synthesis of palladacyclopentadiene complexes 5i and 7i.
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imidazolyl-2-ene}silver bromide (1c) to give light yellow
microcrystals.
Yield: 0.145 g (90%). 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 3.40 (s,
3H, OCH3), 3.42 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 3.72 (s, 3H, NCH3),
3.73 (s, 3H, OCH3), 5.07 (bd, H, NCH2), 5.83 (bd, H, NCH2), 6.78 (d,
J ¼ 1.5 Hz, 1H, CH]CH Im), 7.08 (d, J ¼ 1.5 Hz, 1H, CH]CH Im), 7.33
(ddd, J ¼ 7.7, 5.4, 1.0 Hz, 1H, 5-Pyr), 7.56 (d, J ¼ 7.7 Hz, 1H, 3-Pyr),
7.84 (td, J ¼ 7.7, 1.7 Hz, 1H, 4-Pyr), 8.66 (d, J ¼ 5.4 Hz, 1H, 6-Pyr).
13C{1H } NMR (CDCl3, T ¼ 298 K, ppm) d: 37.4 (CH3, NCH3), 50.3
(CH3, OCH3), 50.9 (CH3, OCH3), 51.2 (CH3, OCH3), 51.2 (CH3, OCH3),
56.5 (CH2, NCH2), 121.3 (CH, CH]CH Im), 121.4 (CH, CH]CH Im),
124.1 (CH, 5-Pyr), 124.7 (CH, 3-Pyr), 138.5 (CH, 4-Pyr), 141.1 (C, C]
C),148.4 (C, C]C),152.7 (C, 6-Pyr),154.1 (CH, 2-Pyr), 155.7 (C, C]C).
164.3 (C, C]O), 166.1 (C, C]O), 175.1 (C, C]O), 175.7 (C, C]O),
177.5 (C, C]C), 180.5 (C, NCN). IR (KBr): 1689 cm1 (nCO). Anal.
Calcd for C22H23N3O8Pd: C, 46.86; H, 4.11; N, 7.45. Found C, 46.78; H,
4.12; N, 7.36%.
4.1.4. Synthesis of {[1-(2-pyridyl)methylene-3-(2,4,6-trimethyl]
imidazolyl-2-ene}Pd- (2a')
The synthesis of the title complex is analogous to that of 2a,
starting from 0.064 g (0.114mmol) of [Pd(C-COOt-Bu)4] and 0.053 g(0.114 mmol) of {[1-(2-pyridyl)methylene-3-(2,4,6-trimethyl]imi-
dazolyl-2-ene}silver bromide (1a) to give a light yellow solid.
Yield 0.076 g (79%). 1H NMR (CD2Cl2, T¼ 298 K, ppm) d: 2.21 (bs,
6H, o-mesityl-CH3), 2.37 (s, 3H, p-mesityl-CH3), 3.24 (s, 3H, OCH3),
3.35 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 3.56 (s, 3H, OCH3), 5.17 (bs,
1H, NCH2), 5.99 (bs, 1H, NCH2), 6.86 (d, J ¼ 1.9 Hz, 1H, CH]CH Im),
7.03 (s, 2H, m-mesityl-H), 7.25 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 7.42
(ddd, J ¼ 7.7, 4.6, 1.3 Hz, 1H, 5-Pyr); 7.60 (d, J ¼ 7.7 Hz, 1H, 3-Pyr);
7.89 (td, J¼ 7.6, 1.7 Hz, 1H, 4-Pyr), 8.64 (d, J ¼ 4.6 Hz, 1H, 6- Pyr). 13C
{1H } NMR (CD2Cl2, 75 MHz, ppm) d: 19.3 (CH3, o-mesityl), 20.6
(CH3, p-mesityl), 50.0 (CH3, COOCH3), 50.8 (CH3, COOCH3), 50.9
(CH3, COOCH3), 51.0 (CH3, COOCH3), 56.3 (CH2, CH2-Pyr), 120.5 (CH,
CH]CH Im),123.6 (CH, CH]CH Im),123.9 (CH, 3-Pyr), 124.4 (CH, 5-
Pyr), 129.5 (CH,m-mesityl), 134.0 (C, o-mesityl), 134.8 (C, i-mesityl),
138.3 (C, C]C), 138.8 (CH, 4-Pyr), 140.2 (C, p-mesityl), 149.0 (C, C]
C), 152.8 (CH, 6-Pyr), 153.9 (C, C]C), 154.4 (C, 2-Pyr), 163.4 (C, CO),
166.0 (C, CO), 173.4 (C, CO), 174.8 (C, CO), 178.3 (C, C]C), 183.0 (C,
NHC). IR (KBr): 1707 cm1 (nCO). Anal. Calcd for C42H55N3O8Pd: C,
60.32; H, 6.63; N, 5.02. Found C, 60.39; H, 6.74; N, 5.12%.
4.1.5. Synthesis of {[1-(2-pyridyl)methylene-3-(2,6-
diisopropylphenyl]imidazolyl-2-ene}Pd(C-COOt-Bu)4 (2b')
This complex was prepared in an analogous manner as that
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and 0.058 g (0.114 mmol) of {[1-(2-pyridyl)methylene-3-(2,6-
diisopropylphenyl)]imidazolyl-2-ene}silver bromide (1b) to yield
a white powder.
Yield 0.078 g (77%) 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 0.59 (bs,
3H, iPr-CH3),1.19 (bs, 3H, iPr-CH3) 1.59 (bs, 6H, iPr-CH3) 2.78 (bs, 2H,
iPr-CH), 3.09 (s, 3H, OCH3), 3.30 (s, 3H, OCH3), 3.53 (s, 3H, OCH3),
3.54 (s, 3H, OCH3), 5.21 (bs,1H, CH2Py), 6.00 (bs,1H, CH2Py), 6.88 (d,
J ¼ 1.8 Hz, 1H CH]CH Im), 7.21 (d, J ¼ 1.8 Hz, 1H CH]CH Im), 7.29
(d, J ¼ 7.7 Hz, 2H, m-Ph), 7.38e7.45 (m, 2H, p-Ph 5-Py), 7.60 (d,
J ¼ 7.7 Hz, 1H, 3-Py), 7.88 (td, J ¼ 7.7, 1.6 Hz, 1H, 4-Py), 8.57 (d,
J ¼ 4.5 Hz, 1H, 6-Py).
13C {1H} NMR (CD2Cl2, ppm) d: 23.7 (CH3, iPr-CH3), 26.8 (CH3,
iPr-CH3), 28.6 (CH, iPr-CH), 50.0 (CH3, OCH3), 50.8 (CH3, two signals
overlapped, OCH3), 51.6 (CH3, OCH3), 56.4 (CH2, CH2-Pyr), 120.3
(CH, CH]CH Im), 123.9 (CH, CH]CH Im), 124.2 (CH, 3-Pyr), 124.2
(CH, m-Ph), 125.2 (CH, 5-Pyr), 129.3 (CH, p-Ph), 134.6 (CH, i-Ph),
138.9 (CH, 4-Pyr), 140.4 (C, C]C), 145.0 (C, o-Ph), 148.1 (C, C]C),
152.2 (CH, 6-Pyr), 154.6 (CH, 2-Pyr), 155.3 (C, C]C), 163.6 (C, CO),
165.8 (C, CO), 173.5 (C, CO), 174.6 (C, CO), 177.0 (C, C]C), 183.8 (C,
NHC). IR (KBr): 1699 cm1 (nCO). Anal. Calcd for C45H61N3O8Pd: C,
61.53; H, 7.00; N, 4.78. Found C, 61.60; H, 6.94; N, 4.88%.
4.1.6. Synthesis of {[1-(2-pyridyl)methylene-3-methyl]imidazolyl-
2-ene}Pd(C-COOt-Bu)4 (2c')
This complex was prepared in an analogous manner as that
described for 2a, using 0.064 g (0.114 mmol) of [Pd(C-COOt-Bu)4]n
and 0.035 g (0.114 mmol) of {[1-(2-pyridyl)methylene-3-methyl]
imidazolyl-2-ene}silver bromide (1c) to give a light yellow powder.
Yield 0.0665 g (81%). 1H NMR (CD2Cl2, T¼ 298 K, ppm) d: 1.19 (s,
9H, C(CH3)3), 1.36 (s, 9H, C(CH3)3), 1.49 (s, 9H, C(CH3)3), 1.50 (s, 9H,
C(CH3)3), 3.85 (s, 3H, NCH3), 4.93 (d, 1H, J ¼ 14.6 Hz, NCH2), 5.83 (d,
1H, J ¼ 14.6 Hz, NCH2), 6.78 (d, J ¼ 1.8 Hz, 1H, CH]CH Im), 7.08 (d,
J ¼ 1.8 Hz, 1H, CH]CH Im), 7.33 (ddd, J ¼ 7.7, 5.3, 0.7 Hz, 1H, 5-Pyr),
7.46 (d, J¼ 7.7 Hz, 1H, 3-Pyr), 7.81 (td, J¼ 7.7, 1.7 Hz, 1H, 4-Pyr), 8.73
(ddd, J ¼ 5.3, 1.7, 0.7 Hz, 1H, 6-Pyr). 13C{1H } NMR (CDCl3, T ¼ 298 K,
ppm) d: 27.9 (CH3, C(CH3)3), 28.3 (CH3, C(CH3)3), 28.4 (CH3,
C(CH3)3), 28.6 (CH3, C(CH3)3), 38.1 (CH3, NCH3), 55.7 (CH2, NCH2),
77.9 (C, C(CH3)3), 79.0 (C, C(CH3)3), 79.3 (C, C(CH3)3), 79.4 (C,
C(CH3)3), 120.7 (CH, CH]CH Im), 121.8 (CH, CH]CH Im), 123.9 (CH,
5-Pyr), 124.5 (CH, 3-Pyr), 138.3 (CH, 4-Pyr), 144.1 (C, C]C), 147.1 (C,
C]C), 153.9 (C, 2-Pyr), 154.1 (CH, 6-Pyr), 158.6 (C, C]C), 164.1 (C,
C]O), 164.5 (C, C]O), 170.4 (C, C]O), 174.8 (C, C]O), 174.8 (C, C]
C), 182.1 (C, NCN). IR (KBr): 1698 cm1 (nCO). Anal. Calcd for
C34H47N3O8Pd: C, 55.77; H, 6.47; N, 5.74. Found C, 55.82; H, 5.39; N,
5.82%.
4.1.7. Synthesis of {[1-(metylthio)methylene-3-(2,4,6-trimethyl)]
imidazolyl-2-ene}Pd(CeCOOMe)4 (2d)
The synthesis of the title complex is analogous to that of 2a,
starting from 0.0900 g (0.231 mmol) of [Pd(CeCOOMe)4] and
0.100 g (0.231 mmol) of {[1-(metylthio)methylene-3-(2,4,6-
trimethyl)]imidazolyl-2-ene}silver bromide (1d) to give a yellow
solid.
Yield 0.124 g (84%). 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 2.28 (bs,
6H, o-aryl-CH3), 2.34 (s, 3H, p-aryl-CH3), 2.37 (s, 3H, SeCH3), 3.13 (s,
3H, OeCH3), 3.56 (s, 3H, OeCH3), 3.59 (s, 3H, OeCH3), 3.70 (s, 3H,
OeCH3), 5.05 (bs, 2H, CH2S), 6.89 (d, J¼ 1.9 Hz,1H, CH]CH Im) 7.02
(bs, 2H, m-aryl-H), 7.36 (d, J ¼ 1.9 Hz, 1H, CH]CH Im).
13C {1H} NMR (CDCl3, T ¼ 298 K, ppm) d: 18.2 (CH3, p-mesityl-
CH3), 19.4 (CH3, o-mesityl-CH3), 20.9 (CH3, SeCH3), 50.9 (CH3,
OeCH3), 51.1 (CH3, OeCH3), 51.2 (CH3, OeCH3), 51.3 (CH3, OeCH3),
55.3 (CH2, SCH2), 120.0 (CH, CH]CH Im), 129.7 (CH,m-mesityl-CH);
134.1(C, i-mesityl-C); 135.2 (C, o-mesityl-C); 143.8 (C, C]C), 151.8
(C, C]C), 154.4 (C, C]C), 163.6 (C, CO), 166.6 (C, CO), 172.1 (C, CO),175.8 (C, C]C), 176.1 (C, CO), 186.0 (C, NCN). IR (KBr):
1695 cm1 (nCO). Anal. Calcd for C26H30N2O8PdS: C, 49.02; H, 4.75;
N, 4.40. Found C, 49.12; H, 4.82; N, 4.36%.
4.1.8. Synthesis of {[1-(metylthio)methylene-3-(2,6-
diisopropylphenyl)]imidazolyl-2-ene}Pd(CeCOOMe)4 (2e)
The synthesis of the title complex is analogous to that of 2a,
starting from 0.0826 g (0.211 mmol) of [Pd(CeCOOMe)4] and
0.1005 g (0.211 mmol) of {[1-(metylthio)methylene-3-(2,6-
diisopropylphenyl)]imidazolyl-2-ene}silver bromide (1e) to give a
yellow solid.
Yield 0.119 (83%). 1H NMR (CDC3, T ¼ 233 K, ppm) d: 0.80 (d,
J ¼ 6.9 Hz, 3H, iPr-CH3), 1.20 (d, J ¼ 6.9 Hz, 3H, iPr-CH3), 1.43 (d,
J ¼ 6.9 Hz, 6H, iPr-CH3), 1.44 (d, J ¼ 6.9 Hz, 6H, iPr-CH3), 2.26 (s, 3H,
SeCH3), 2.59 (sept, 1H, J ¼ 6.9 Hz, iPr-CH), 2.96 (s, 3H, OeCH3), 3.52
(s, 3H, OeCH3), 3.54 (sept partially obscured, 1H, J¼ 6.8 Hz, iPr-CH),
3.52 (s, 3H, OeCH3), 3.56 (s, 3H, OeCH3), 3.68 (s, 3H, OeCH3), 4.83
(d, 1H, J ¼ 13.2 Hz, CH2S), 5.28 (d, 1H, J ¼ 13.2 Hz, CH2S), 6.96 (d,
J¼ 1.9 Hz,1H, CH]CH Im), 7.29 (d, J¼ 7.9 Hz,1H,m-aryl-H), 7.39 (d,
J¼ 1.9 Hz, 1H, CH]CH Im), 7.45 (t, J ¼ 7.9 Hz, 1H, p-aryl-H). 13C {1H}
NMR (CDCl3, T ¼ 298 K, ppm) d: 17.9 (CH3, SeCH3), 22.2 (bs, CH3,
iPr-CH3), 25.9 (bs, CH3, iPr-CH3), 28.8 (bs, CH3, iPr-CH3), (CH, iPr-CH
not detectable), 50.9 (CH3, OeCH3), 51.1 (CH3, OeCH3), 51.3 (CH3,
OeCH3), 51.7 (CH3, OeCH3), 55.1 (CH2, SCH2), 119.9 (CH, CH]CH
Im), 124.4 (CH, m-aryl-CH); 125.6 (CH, CH]CH Im), 129.4 (CH, p-
aryl-CH); 135.3 (C, i-aryl-C); 143.1 (C, C]C), 144.6 (C, o-aryl-C);
151.9 (C, C]C), 153.9 (C, C]C), 163.4 (C, CO), 166.9 (C, CO), 172.0 (C,
CO), 176.1 (C, CO), 176.7 (C, C]C), 186.4 (C, NCN). IR (KBr):
1697 cm1 (nCO). Anal. Calcd for C29H36N2O8PdS: C, 51.29; H, 5.34;
N, 4.13. Found C, 51.36; H, 5.39; N, 4.21%.
4.1.9. {k1-C-[1-(2-pyridyl)methylene-3-methyl]imidazolyl-2-
ene}2Pd(CeCOOMe)4 (3c)
0.1180 g (0.328 mmol) of {[1-(2-pyridyl)methylene-3-methyl]
imidazolyl-2-ene}silver bromide (1c) dissolved in 5 mL of anhy-
drous dichloromethane was added to 15 mL of a solution of
[Pd(CeCOOMe)4]n (0.064 g, 0.164 mmol) in the same solvent. The
mixture was stirred for 30 min at RT, whereupon the greyish silver
salt precipitated and then ﬁltered through a Millipore ﬁlter. The
clear solution was concentrated under reduced pressure and
addition of diethylether induced precipitation of the ﬁnal product
as a whitish solid, which was ﬁltered off and washed with dieth-
ylether and n-pentane.
Yield 0.106 g (90%). 1H NMR (CDCl3, T¼ 298 K, ppm): syn-isomer
d: 3.18 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 3.88 (s, 3H, NCH3), 5.27, 5.32
(AB system, J ¼ 16.1 Hz, 2H, NCH2), 6.86 (d, J ¼ 1.9 Hz, 1H, CH]CH
Im), 6.90 (d, J¼ 1.9 Hz,1H, CH]CH Im), 7.12 (ddd, J¼ 7.7, 4.9, 1.0 Hz,
1H, 5-Pyr), 7.24 (d, J ¼ 7.7 Hz, 1H, 3-Pyr), 7.56 (td, J ¼ 7.7, 1.7 Hz, 1H,
4-Pyr), 8.42 (d, J ¼ 4.9 Hz, 1H, 6-Pyr); anti-isomer d: 3.25 (s, 3H,
OCH3), 3.58 (s, 3H, NCH3), 3.63 (s, 3H, OCH3), 5.32, (d J¼ 16.1 Hz,1H,
NCH2), 5.71, (d J¼ 16.1 Hz,1H, NCH2), 6.65 (d, J¼ 1.9 Hz,1H, CH]CH
Im), 6.78 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 7.07 (d, J ¼ 7.7 Hz, 1H, 3-
Pyr), 7.18 (ddd, J ¼ 7.7, 4.9, 1.0 Hz, 1H, 5-Pyr), 7.54 (td, J ¼ 7.7,
1.7 Hz, 1H, 4-Pyr), 8.47 (d, J ¼ 4.9 Hz, 1H, 6-Pyr).
13C{1H } NMR (CDCl3, T ¼ 298 K, ppm) syn-isomer d: 38.0 (CH3,
NCH3), 50.5 (CH3, OCH3), 50.9 (CH3, OCH3), 55.6 (CH2, NCH2), 121.0
(CH, CH]CH Im), 121.9 (CH, CH]CH Im), 122.6 (CH, 5-Pyr), 123.5
(CH, 3-Pyr), 136.8 (CH, 4-Pyr), 144.2 (C, C]C), 149.2 (C, 6-Pyr), 155.0
(CH, 2-Pyr), 165.2 (C, C]O),169.2 (C, C]C), 176.9 (C, C]O),181.3 (C,
NCN); anti-isomer d: 37.4 (CH3, NCH3), 50.5 (CH3, OCH3), 50.9 (CH3,
OCH3), 55.6 (CH2, NCH2), 120.6 (CH, CH]CH Im), 122.0 (CH, 3-Pyr),
122.3 (CH, CH]CH Im), 122.7 (CH, 5-Pyr), 136.8 (CH, 4-Pyr), 143.9
(C, C]C), 149.2 (C, 6-Pyr), 155.7 (CH, 2-Pyr), 165.3 (C, C]O), 169.2
(C, C]C),176.9 (C, C]O),182.0 (C, NCN).). IR (KBr): 1692 cm1 (nCO).
Anal. Calcd for C32H34N6O8Pd: C, 52.14; H, 4.65; N, 11.40. Found C,
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4.1.10. Synthesis of {k1-C-[metylthio)methylene-3-methyl]
imidazolyl-2-ene}2Pd(CeCOOMe)4 (3f)
This complex was prepared in an analogous manner as that
described for 3c, using.
0.112 g (0.338 mmol) of {[1-(metylthio)methylene-3-methyl]
imidazolyl-2-ene} silver bromide (1f) and 0.066 g (0.169 mmol) of
[Pd(CeCOOMe)4]n.
Yield 0.097 g (87%; off-white solid) 1H NMR (CDCl3, T ¼ 298 K,
ppm) d: syn-isomer d: 2.10 (s, 3H, SCH3), 3.31 (s, 3H, OCH3), 3.63 (s,
3H, OCH3), 3.83 (s, 3H, NCH3), 4.94 (d, J¼ 13.8 Hz,1H, SCH2), 5.09 (d,
J ¼ 13.9 Hz, 1H, SCH2), 6.92 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 7.26 (d,
J¼ 1.9 Hz,1H, CH]CH Im); anti-isomer d: 1.87 (s, 3H, SCH3), 3.30 (s,
3H, OCH3), 3.63 (s, 3H, OCH3), 4.00 (s, 3H, NCH3), 4.94 (d,
J ¼ 13.9 Hz, 1H, SCH2), 5.26 (d, J ¼ 13.9 Hz, 1H, SCH2), 6.96 (d,
J ¼ 1.9 Hz, 1H, CH]CH Im), 7.19 (d, J ¼ 1.9 Hz, 1H, CH]CH Im).
13C{1H } NMR (CDCl3, T ¼ 298 K, ppm) syn-isomer d: 15.2 (CH3,
SCH3), 38.1 (CH3, NCH3), 50.5 (CH3, OCH3), 50.9 (CH3, OCH3), 53.3
(CH2, SCH2), 119.9 (CH, CH]CH Im), 122.4 (CH, CH]CH Im), 144.3
(C, C]C), 165.1 (C, C]O), 168.5 (C, C]C), 176.7 (C, C]O), 181.3 (C,
NCN). anti-isomer d: 13.9 (CH3, SCH3), 38.3 (CH3, NCH3), 50.5 (CH3,
OCH3), 50.9 (CH3, OCH3), 54.0 (CH2, SCH2), 119.7 (CH, CH]CH Im),
122.7 (CH, CH]CH Im),144.3 (C, C]C),165.1 (C, C]O),168.4 (C, C]
C), 176.7 (C, C]O), 181.5 (C, NCN). IR (KBr): 1692 cm1 (nCO). Anal.
Calcd for C24H32N4O8PdS2: C, 42.70; H, 4.78; N, 8.30. Found C,
42.88; H, 4.88; N, 8.39%.
4.1.11. Synthesis of {k1-C-[metylthio)methylene-3-phenyl]
imidazolyl-2-ene}2Pd(CeCOOMe)4 (3g)
This complex was prepared in an analogous manner as that
described for 3c, using.
0.129 g (0.328 mmol) of {[1-(metylthio)methylene-3-phenyl]
imidazolyl-2-ene} silver bromide (1g) and 0.064 g (0.164 mmol) of
[Pd(CeCOOMe)4]n.
Yield 0.113 g (86%; light brown solid). 1H NMR (CDCl3, T¼ 298 K,
ppm) syn-isomer d: 3.28 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 3.82 (s,
3H, NCH3), 5.45 (d, J ¼ 14.3 Hz, 1H, SCH2), 5.92 (d, J ¼ 143 Hz, 1H,
SCH2), 6.79e6.84 (m, 2H, CH]CH Im), 7.24e7.27 (m, 5H, SPh); anti-
isomer d: 3.26 (s, 3H, OCH3), 3.62 (s, 3H, OCH3), 3.84 (s, 3H, NCH3),
5.26 (d, J ¼ 14.2 Hz, 1H, SCH2), 5.90 (d, J ¼ 14.2 Hz, 1H, SCH2), 6.96
(d, J ¼ 1.8 Hz, 1H, CH]CH Im), 6.79e6.84 (m, 1H, CH]CH Im,
overlapped to the corresponding signals of the endo isomer),
7.24e7.27 (m, 5H, SPh).
13C{1H } NMR (CDCl3, T ¼ 298 K, ppm) syn-isomer d: 38.1 (CH3,
NCH3), 50.6 (CH3, OCH3), 50.9 (CH3, OCH3), 54.9 (CH2, SCH2), 120.2
(CH, CH]CH Im), 122.2 (CH, CH]CH Im), 127.7 (CH, Ph p-C), 129.3
(CH, Ph o-C), 131.0 (CH, Ph m-C), 133.6 (C, Ph i-C), 144.1 (C, C]C),
165.1 (C, C]O), 168.4 (C, C]C), 176.7 (C, C]O), 181.5 (C, NCN); anti-
isomer d: 38.1 (CH3, NCH3), 50.6 (CH3, OCH3), 50.9 (CH3, OCH3), 54.9
(CH2, SCH2), 120.0 (CH, CH]CH Im), 122.6 (CH, CH]CH Im), 128.1
(CH, Ph p-C), 129.4 (CH, Ph o-C), 131.5 (CH, Phm-C), 133.3 (C, Ph i-C),
143.9 (C, C]C), 165.0 (C, C]O), 168.4 (C, C]C), 176.8 (C, C]O),
181.4 (C, NCN). IR (KBr): 1689 cm1 (nCO). Anal. Calcd for
C34H36N4O8PdS2: C, 51.10; H, 4.54; N, 7.01. Found C, 51.18; H, 4.60; N,
7.12%.
4.1.12. Synthesis of {k1-C-{[1-benzyl-3-methyl]imidazolyl-2-
ene}2Pd(CeCOOMe)4 (3h)
This complex was prepared in an analogous manner as that
described for 3c, using 0.118 g (0.328 mmol) of {[1-benzyl-3-
methyl]imidazolyl-2-ene}silver bromide (1h) and 0.064 g
(0.164 mmol) of [Pd(CeCOOMe)4]n.
Yield 0.114 g (94%; white solid). 1H NMR (CDCl3, T¼ 298 K, ppm)
syn-isomer d: 3.31 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 3.95 (s, 3H,NCH3), 5.28 (d, J¼ 15.1 Hz,1H, NCH2), 5.74 (d, J¼ 15.1 Hz,1H, NCH2),
6.55 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 6.87 (d, J ¼ 1.9 Hz, 1H, CH]CH
Im), 6.88e6.90 (m, 2H, Ph), 7.20e7.30 (m, 3H, Ph); anti-isomer d:
3.29 (s, 3H, OCH3), 3.55 (s, 3H, NCH3), 3.64 (s, 3H, OCH3), 5.19 (d,
J ¼ 15.8 Hz, 1H, NCH2), 5.74 (d, J ¼ 15.8 Hz, 1H, NCH2), 6.71 (s, 2H,
CH]CH Im), 6.88e6.90 (m, 2H, Ph), 7.20e7.30 (m, 3H, Ph). 13C{1H}
NMR (CDCl3, T ¼ 298 K, ppm) syn-isomer d: 38.1 (CH3, NCH3), 50.5
(CH3, OCH3), 50.9 (CH3, OCH3), 54.0 (CH2, NCH2), 120.3 (CH, CH]CH
Im), 121.9 (CH, CH]CH Im), 128.0 (CH, Ph p-C), 128.1 (CH, Ph o-C),
128.7 (CH, Phm-C), 135.2 (C, Ph i-C), 143.9 (C, C]C), 165.2 (C, C]O),
169.0 (C, C]C), 176.9 (C, C]O), 181.8 (C, NCN); anti-isomer d: 37.2
(CH3, NCH3), 50.5 (CH3, OCH3), 50.9 (CH3, OCH3), 54.0 (CH2, NCH2),
120.4 (CH, CH]CH Im), 122.5 (CH, CH]CH Im), 126.7 (CH, Ph o-
C),127.9 (CH, Ph p-C), 128.7 (CH, Ph m-C), 135.9 (C, Ph i-C), 143.7 (C,
C]C), 165.1 (C, C]O), 169.0 (C, C]C), 176.9 (C, C]O), 182.0 (C,
NCN). IR (KBr): 1692 cm1 (nCO). Anal. Calcd for C34H36N4O8Pd: C,
55.55; H, 4.94; N, 7.62. Found C, 55.64; H, 4.92; N, 7.56%.
4.1.13. Synthesis of {k1-C-{[1-(4-methylphenyl)methylene-3-
methyl]imidazolyl-2-ene}2 Pd(CeCOOMe)4 (3i)
This complex was prepared in an analogous manner as that
described for 3c, using 0.123 g (0.328 mmol) of {[1-(4-
methylphenyl)methylene-3-methyl]imidazolyl-2-ene}silver bro-
mide (1h) and 0.064 g (0.164 mmol) of [Pd(CeCOOMe)4]n.
Yield 0.109 g (87%; light brown solid). 1H NMR (CDCl3, T¼ 298 K,
ppm) syn-isomer d: 2.31 (s, 3H, tolyl-CH3), 3.30 (s, 3H, OCH3), 3.65
(s, 3H, OCH3), 3.93 (s, 3H, NCH3), 5.09 (d, J¼ 15.0 Hz,1H, NCH2), 5.21
(d, J ¼ 15.0 Hz, 1H, NCH2), 6.55 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 6.85
(d, J¼ 1.9 Hz,1H, CH]CH Im), 6.79 (d, J¼ 8.2 Hz, 2H, toyl o-H), 7. 04
(d, J ¼ 8.2 Hz, 2H, toyl m-H); anti-isomer d: 2.33 (s, 3H, tolyl-CH3),
3.29 (s, 3H, OCH3), 3.60 (s, 3H, NCH3), 3.64 (s, 3H, OCH3), 5.14 (d,
J ¼ 15.6 Hz, 1H, NCH2), 5.66 (d, J ¼ 15.6 Hz, 1H, NCH2), 6.69 (d,
J ¼ 1.9 Hz, 1H, CH]CH Im), 6.73 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 6.78
(d, J ¼ 8.2 Hz, 2H, tolyl o-H), 7. 06 (d, J ¼ 8.2 Hz, 2H, tolyl m-H). 13C
{1H} NMR (CDCl3, T ¼ 298 K, ppm) syn-isomer d: 27.7 (CH3, tolyl-
CH3), 36.1 (CH3, NCH3), 48.6 (CH3, OCH3), 48.9 (CH3, OCH3), 51.8
(CH2, NCH2), 118.3 (CH, CH]CH Im), 119.8 (CH, CH]CH Im), 126.2
(CH, tolyl o-C), 127.4 (CH, tolyl m-C), 130.2 (C, tolyl p-C), 135.8 (C,
tolyl i-C), 142.3 (C, C]C), 163.2 (C, C]O), 167.2 (C, C]C), 175.0 (C,
C]O),179.7 (C, NCN); anti-isomer d: 19.1 (CH3, toyl-CH3), 35.5 (CH3,
NCH3), 48.6 (CH3, OCH3), 48.9 (CH3, OCH3), 51.9 (CH2, NCH2), 118.3
(CH, CH]CH Im),120.5 (CH, CH]CH Im),125.0 (CH, tolyl o-C), 127.5
(CH, tolyl m-C), 130.9 (C, tolyl p-C), 135.8 (C, tolyl i-C), 141.8 (C, C]
C), 163.2 (C, C]O),167.2 (C, C]C), 175.0 (C, C]O), 179.9 (C, NCN). IR
(KBr): 1692 cm1 (nCO). Anal. Calcd for C36H40N4O8Pd: C, 56.66; H,
5.28; N, 7.34. Found C, 56.78; H, 5.36; N, 7.39%.
4.1.14. {k1-C-[1-(2-pyridyl)methylene-3-methyl]imidazolyl-2-
ene}(PPh3)Pd(CeCOOMe)4 (5c)
0.064 g (0.120 mmol) of {[1-(2-pyridyl)methylene-3-methyl]
imidazolyl-2-ene}Pd(CeCOOMe)4 were dissolved in 15 mL of
anhydrous dicloromehane. To this solution was slowly added
0.0336 g (0.128 mmol) of triphenylphosphine and the mixture was
stirred for 15 min. Evaporation under vacuum to a small volume
and addition of diethylether induced the precipitation of the ﬁnal
product as a light yellow solid. It was ﬁltered off and washed with
diethylether and n-pentane.
Yield 0.081 g (83%). 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 2.55 (s,
3H, OCH3), 3.10 (s, 3H, OCH3), 3.23 (s, 3H, NCH3), 3.63 (s, 3H, OCH3),
3.64 (s, 3H, OCH3), 5.08 (d, J ¼ 14.6 Hz, 1H, NCH2), 5.32 (d,
J ¼ 14.8 Hz, 1H, NCH2), 6.50 (d, J ¼ 1.8 Hz, 1H, CH]CH Im), 6.95 (d,
J¼ 1.8 Hz,1H, CH]CH Im), 7.14 (m,1H, 5-Pyr), 7.22e7.39 (m,16H, 3-
Pyr, PPh), 7.52 (td, J ¼ 7.5, 1.6 Hz, 1H, 4-Pyr), 8.28 (d, J ¼ 4.7 Hz, 1H,
6-Pyr). 13C {1H} NMR (CDCl3, T ¼ 298 K, ppm) d: 36.8 (CH3, NCH3),
49.8 (CH3, OCH3), 50.6 (CH3, OCH3), 51.0 (CH3, OCH3), 51.1 (CH3,
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Im), 122.8 (CH, 5-Pyr), 124.2 (CH, 3-Pyr), 136.8 (CH, 4-Pyr), 145.2 (C,
C]C), 148.1 (C, C]C), 149.0 (C, 6-Pyr), 154.1 (CH, 2-Pyr), 164.3 (C,
C]O), 165.1 (C, C]C), 166.5 (C, C]O), 174.9 (C, C]C), 175.0 (C, C]
O), 175.7 (C, C]O), 179.2 (C, NCN). 31P {1H} NMR (CDCl3, T ¼ 298 K,
ppm) d: 27.4 (s, PPh3). IR (KBr): 1697 cm1 (nCO). Anal. Calcd for
C40H38N3O8PPd: C, 58.15; H, 4.64; N, 5.09. Found C, 58.20; H, 4.70;
N, 5.18%.
4.1.15. {k1-C-[1-(2-pyridyl)methylene-3-methyl]imidazolyl-2-ene}
{P(OEt)3}Pd(CeCOOMe)4 (6c)
This complex was prepared in an analogous manner as that
described for 5c, starting from 0.051 g (0.092 mmol) of {[1-(2-
pyridyl)methylene-3-methyl]imidazolyl-2-ene}Pd(CeCOOMe)4
and 0.0172 mL (0.099 mmol) of triethyl phoshite.
Yield 0.058 g (87% white solid). 1H NMR (CDCl3, T¼ 298 K, ppm)
d: 1.16 (t, J ¼ 7.0 Hz, 9H, POCH2CH3), 3.19 (s, 3H, OCH3), 3.63 (s, 3H,
OCH3), 3.67 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 4.03 (s, 3H, NCH3),
3.91 (m, 6H, POCH2CH3), 5.43, 5.40 (AB system, J ¼ 15.0 Hz, 2H,
NCH2), 6.91 (d, J ¼ 1.9 Hz, 1H, CH]CH Im), 7.04 (d, J ¼ 1.9 Hz, 1H,
CH]CH Im), 7.27 (ddd, J ¼ 7.7,4.9,1.0 Hz, 1H, 5-Pyr), 7.53 (d,
J ¼ 7.7 Hz, 1H, 3-Pyr), 7.72 (td, J ¼ 7.7, 1.8 Hz, 1H, 4-Pyr), 8.60 (d,
J ¼ 4.8 Hz, 1H, 6-Pyr).13C {1H } NMR (CDCl3, T ¼ 298 K, ppm) d:
16.1(d, JCP ¼ 7.2 Hz, CH3, POCH2CH3) 37.4 (CH3, NCH3), 50.6 (CH3,
OCH3), 50.8 (CH3, OCH3), 51.1 (2 CH3, OCH3), 56.0 (CH2, NCH2), 61.0
(CH2, POCH2CH3) 121.3 (CH, CH]CH Im), 122.1 (CH, CH]CH Im),
123.1 (CH, 5-Pyr), 123.8 (CH, 3-Pyr), 137.0 (CH, 4-Pyr), 146.5 (C, C]
C), 146.7 (C, C]C), 149.3 (C, 6-Pyr), 154.9 (CH, 2-Pyr), 164.4 (C, C]
O), 166.6 (C, C]O), 169.9 (C, C]C), 175.5 (C, C]O), 176.4 (C, C]C),
176.5 (C, C]O), 178.2 (C, NCN).
31P {1H } NMR (CDCl3, T ¼ 298 K, ppm) d: 127.2 (s, P(OEt)3). IR
(KBr): 1696 cm1 (nCO). Anal. Calcd for C28H38N3O11PPd: C, 46.07; H,
5.25; N, 5.76. Found C, 46.14; H, 5.32; N, 5.82%.
4.1.16. {k1-C-[1-(2-pyridyl)methylene-3-methyl]imidazolyl-2-
ene}(DIC)Pd(CeCOOMe)4 (7c)
This complex was prepared in an analogous manner as that
described for 5c, starting from 0.065 g (0.118 mmol) of {[1-(2-
pyridyl)methylene-3-methyl]imidazolyl-2-ene}Pd(CeCOOMe)4
and 0.0162 g (0.123 mmol) of DIC (2,6 dimethyl isocyanide).
Yield 0.0714 g (89%; light yellow solid). 1H NMR (CDCl3,
T ¼ 298 K, ppm) d: 2.10 (s, 6H, aryl-CH3), 3.29 (s, 3H, OCH3), 3.61 (s,
3H, OCH3), 3.66 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 3.86 (s, 3H, NCH3),
5.22 (d, J ¼ 14.8 Hz, 1H, NCH2), 5.65 (d, J ¼ 14.8 Hz, 1H, NCH2), 6.97
(d, J¼ 1.8 Hz,1H, CH]CH Im), 7.01 (m,1H, 5-Pyr), 7.04 (d, J¼ 7.8 Hz,
2H, aryl m-H), 7.20 (d, J¼ 7.8 Hz,1H aryl p-H), 7.21 (d, J¼ 1.8 Hz,1H,
CH]CH Im), 7.60e7.63 (m, 2H, 3-Pyr, 4-Pyr), 8.28 (d, J ¼ 4.8 Hz, 1H,
6-Pyr).
13C {1H} NMR (CDCl3, T¼ 298 K, ppm) d: 18.1 (CH3, Ar-CH3), 37.8
(CH3, NCH3), 50.7 (CH3, OCH3), 50.8 (CH3, OCH3), 51.1 (CH3, OCH3),
51.2 (CH3, OCH3), 55.9 (CH2, NCH2), 122.0 (CH, CH]CH Im), 122.5
(CH, 5-Pyr), 122.8 (CH, CH]CH Im), 123.9 (CH, 3-Pyr), 126.7 (C, aryl
i-C), 127.8 (CH, aryl m-C), 129.5 (CH, aryl p-C), 135.1 (C, aryl o-C),
136.9 (CH, 4-Pyr), 145.3 (C, C]C), 146.3 (C, C]C), 149.3 (C, 6-Pyr),
155.1 (CH, 2-Pyr), 164.4 (C, C]O), 165.1 (C, C]O), 166.2 (C, C]C),
166.3 (C, C]C), 175.2 (C, C]O), 176.1 (C, C]O), 177.8 (C, NCN). IR
(KBr): 1697 cm1 (nCO); 2174 cm1 (nCN). Anal. Calcd for
C31H32N4O8Pd: C, 53.57; H, 4.64; N, 8.06. Found C, 53.64; H, 4.56; N,
8.12%.
4.1.17. Synthesis of {k1-C-{[1-(4-methylphenyl)methylene-3-
methyl]imidazolyl-2-ene}(PPh3)Pd(CeCOOMe)4 (5i)
0.050 g (0.128 mmol) of the polymer [Pd(CeCOOMe)4]n was
dissolved in 15mL of anhydrous dicloromehane and to this solution
were successively added 0.034 g (0.128 mmol) oftriphenylphosphine and 0.0480 g of {[1-(4-methylphenyl)methy-
lene-3-methyl]imidazolyl-2-ene}silver bromide (1i). The mixture
was stirred for 30 min at RT upon which the greyish silver salt
precipitated; after ﬁltration through a Millipore ﬁlter the resulting
solution was concentrated under reduced pressure and the addi-
tion of diethylether induced the precipitation of the ﬁnal product as
awhitish solid. It was ﬁltered off and washed with diethylether and
n-pentane.
Yield 0.090 g (80%). 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 2.33 (s,
3H, tolyl-CH3), 2.56 (s, 3H, OCH3), 3.21 (s, 3H, OCH3), 3.33 (s, 3H,
NCH3), 3.62 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 4.56 (d, J¼ 13.8 Hz,1H,
NeCH2), 5.22 (d, J ¼ 13.8 Hz, 1H, NeCH2), 6.29 (d, J ¼ 1.8 Hz, 1H,
CH]CH Im), 6.51 (d, J ¼ 1.8 Hz, 1H, CH]CH Im), 6.86 (d, J ¼ 7.9 Hz,
2H, tolylm-H), 7.06 (d, J ¼ 7.9 Hz, 2H, tolyl o-H), 7,29e7.44 (m, 15H,
PPh3). 13C {1H} NMR (CDCl3, T¼ 298 K, ppm) d: 21.1 (CH3, tolyl-CH3),
37.0 (CH3, NCH3), 49.8 (CH3, OCH3), 50.7 (CH3, OCH3), 51.0 (CH3,
OCH3), 51.1 (CH3, OCH3), 53.8 (CH2, NCH2), 120.0 (CH, CH]CH Im),
121.5 (CH, CH]CH Im), 129.4 (CH, tolyl o-C), 129.9 (CH, tolyl m-C),
130.6 (C, tolyl i-C), 138.3 (C, tolyl p-C),145.5 (C, d, JCP¼ 5.7 Hz, C]C),
148.2 (C, d, JCP ¼ 7.5 Hz, C]C), 165.1 (C, d, JCP ¼ 9.7 Hz, CO), 166.6
(C,CO), 170.0 (C, C]C), 171.5 (C, C]C), 174.9 (C, d, JCP ¼ 4.6 Hz, CO),
175.7 (C, d, JCP¼ 5.1 Hz, CO), 178.9 (C, d, JCP¼ 16.5 Hz, NCN). 31P{1H}
NMR (CDCl3, T ¼ 298 K, ppm) d: 27.5. IR (KBr): nC]O ¼ 1695,
1794 cm11 (nCO). Anal. Calcd for C42H41N2O8PPd: C, 60.11; H, 4.92;
N, 3.34. Found C, 60.27; H, 4.84; N, 3.39%.
4.1.18. Synthesis of {k1-C-{[1-(4-methylphenyl)methylene-3-
methyl]imidazolyl-2-ene}(DIC)Pd(CeCOOMe)4 (7i)
To a solution of [Pd(CeCOOMe)4]n (0.064 g, 0.164 mmol) in
10 mL of anhydrous dichloromethane were successively added
0.0215 g (0.164 mmol) of DIC (2,6 dimethyl isocyanide) and 0.061 g
(0.164 mmol) of {[1-(4-methylphenyl)methylene-3-methyl]imida-
zolyl-2-ene}silver bromide (1i). The mixture was stirred for two
days in the dark and then passed through a Millipore ﬁlter to
remove the silver bromide. The clear solution was evaporated to
dryness and the resulting residue was treated with diethylether to
give a whitish solid. After ﬁltration the product was washed with
small portions of diethylether and n-pentane.
Yield 0.082 g (71%). 1H NMR (CDCl3, T ¼ 298 K, ppm) d: 2.13 (s,
6H, aryl-CH3), 2.15 (s, 3H, tol-CH3), 3.31 (s, 3H, OCH3), 3.59 (s, 3H,
OCH3), 3.65 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 3.87 (s, 3H, NCH3),
5.09 (d, J ¼ 15.0 Hz, 1H, NeCH2), 5.58 (d, J ¼ 15.0 Hz, 1H, NeCH2),
6.94e6.97 (m, 4H, CH]CH Im, tolm-H), 7.06 (d, J ¼ 7.6 Hz, 2H, aryl
m-H), 7.14 (d, J¼ 8.0 Hz, 2H, tol o-H), 7.21 (t, J¼ 7.6 Hz, aryl p-H). 13C
{1H} NMR (CDCl3, T¼ 298 K, ppm) d: 18.6 (CH3, aryl-CH3), 21.3 (CH3,
tol-CH3), 38.2 (CH3, NCH3), 51.2 (CH3, OCH3), 51.3 (CH3, OCH3), 51.5
(CH3, OCH3), 51.6 (CH3, OCH3), 54.8 (CH2, NCH2), 121.9 (CH, CH]CH
Im), 122.8 (CH, CH]CH Im), 126.5 (C, aryl i-C), 128.3 (CH, arylm-C),
128.4 (CH, tol o-C), 129.7 (CH, tolm-C), 129.9 (CH, aryl p-C), 133.3 (C,
tol i-C), 135.5 (C, aryl o-C), 138.3 (C, tol p-C), 145.9 (C, C]C), 146.7 (C,
C]C), 150.5 (C,CN), 164.8 (C, CO), 165.6 (C,CO), 166.6 (C, C]C), 166.9
(C, C]C), 175.7 (C, CO), 176.5 (C, CO), 178.4 (C, NCN). IR (KBr):
nCO ¼ 1697; nCN ¼ 2174 cm1. Anal. Calcd for C33H35N3O8Pd: C,
55.98; H, 4.98; N, 5.93. Found C, 55.88; H, 4.88; N, 5.98%.
4.2. Kinetics measurements
The isomerization process of complex 3c was studied by
monitoring the concentration of the two isomeric species by inte-
gration of suitable 1H NMR signals; the concentrations of the
involved species were independently determined and their internal
consistency was assured by the relevant mass balance equations.
The NMR tube for the determination was prepared by dissolving
8 mg of the product in 0.8 mL of CDCl3. Non-linear analysis of the
data related to kinetics measurements was performed by a locally
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4.3. Crystal structure determinations
The crystal data of compounds 2c and 3iwere collected at room
temperature using a Nonius Kappa CCD diffractometer with
graphite monochromated Mo-Ka radiation. The data sets were in-
tegrated with the Denzo-SMN package [27] and corrected for Lor-
entz, polarization and absorption effects (SORTAV) [28]. The
structure was solved by direct methods using the SIR97 [29] system
of programs and reﬁned using full-matrix least-squares with all
non-hydrogen atoms anisotropically and hydrogens included on
calculated positions, riding on their carrier atoms.
All calculations were performed using SHELXL-97 [30] and
PARST [31] implemented in the WINGX [32] system of programs.
The crystal data are given in Table 1S.
Crystallographic data (excluding structure factors) have been
deposited at the Cambridge Crystallographic Data Centre and
allocated the deposition numbers CCDC 1059980 and 1059981
These data can be obtained free of charge via www.ccdc.cam.ac.uk/
conts/retrieving.html or on application to CCDC, Union Road,
Cambridge, CB2 1EZ, UK [fax: (þ44)1223e336033, e-mail:
deposit@ccdc.cam.ac.uk]
4.4. Computational details
The geometrical optimization of the complexes was carried out
without symmetry constraint, using the hyper-GGA functional MO6
[33,34] in combination with polarized triple-z-quality basis sets
(LAN2TZ(f)) [35,36] and relativistic pseudopotential for the Pd
atoms and a polarized double-z-quality basis sets (6e31 G(d,p)) for
the other elements.
Solvent effects (dichloromethane, ε ¼ 8.93) were included using
CPCM [37,38].
The “restricted” formalism was applied in all the calculations.
The zero-point vibrational energies and thermodynamic parame-
ters were obtained [39] by means of the stationary points charac-
terized by IR simulation.
The software used was Gaussian '09 [40] and all the computa-
tional work was carried out on Intel based x86-64 workstations.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jorganchem.2015.07.014.
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